Closed call · historical reference
Scope:Specific Challenge Current therapies for type 2 diabetes focus on the control of blood glucose levels rather than the modification of the disease. Therefore more robust delineation of clinical risk factors, phenotypes, and molecular biomarkers is needed to identify individuals at risk of rapi…
Topics
Partner types
clinical_research_consortium, healthcare_provider, research_institution, university
